The Cigna Group
CI · NYSE
Analyst Consensus
Buy
Analyst Ratings Synthesis
Consensus is Buy across 21 analysts, with a stated mean price target of $340. Low and high targets are not supplied, so the target range, clustering, and spread cannot be measured. The evidence does not identify the most bullish or least bullish analyst, any named firm-level target, or any analyst rating or target revision during the past week. The substantive disagreement behind the available valuation gap therefore cannot be established from the supplied material. The only documented outlook change was management’s further increase to its fiscal 2026 adjusted earnings outlook, not a consensus revision.
Rating Actions
No individual rating actions have been captured for CIyet. Consensus figures above come from Nasdaq's aggregate feed.
